Best GLP-1 Approach for Maintenance

Most GLP-1 guidance stops at reaching a goal weight, which leaves patients at exactly the point where the evidence says the risk is highest. Maintenance is not an afterthought to weight loss — given what happens on discontinuation, it is arguably the more important phase.

How We Assessed These

Maintenance changes what matters in a provider. Cost sustainability and dose flexibility outrank speed of results.

Why Stopping Usually Reverses the Result

The evidence here is unusually consistent. A Lancet eClinicalMedicine analysis found individuals discontinuing GLP-1 receptor agonist therapy regain a majority of the weight lost during treatment. A 2025 meta-analysis concluded regain is common and drug-dependent. Harvard Health reports people who cease these medications typically regain an average of nearly a pound per month, and clinical reporting associates abrupt discontinuation with regaining roughly 50% to 80% of lost weight.

Trial data on tirzepatide withdrawal has also shown reversal of cardiometabolic benefits alongside weight regain — the losses are not only cosmetic.

The Maintenance Dose Option

For many patients the right answer is not stopping but stepping down. Remaining on a lower maintenance dose can preserve much of the benefit at reduced cost and side-effect burden compared with full-dose therapy or discontinuation.

Because pricing in this category is tiered by dose, a lower maintenance dose is often meaningfully cheaper — which matters given that cost is among the most common reasons people stop. Raise this explicitly before any decision to discontinue.

If You Must Stop, Taper

Clinical guidance commonly describes gradual dose reduction — on the order of 10-25% every four to six weeks — rather than an abrupt halt, on the rationale that appetite regulation adjusts progressively rather than all at once.

Evidence directly comparing tapering with abrupt cessation remains limited, so treat this as a physiologically motivated strategy rather than a proven one. Design it with a prescriber rather than improvising.

Questions Worth Asking Before You Enrol

• What maintenance dose would you consider for me, and when?
• Does my cost drop at a lower dose?
• What does long-term monitoring look like at one, two, five years?
• If I need to stop, what tapering plan would you use?
• What habits should I establish now while appetite is still suppressed?

A provider that answers these clearly is managing a treatment plan. One that deflects to a monthly price is selling a subscription.